Some of Australia’s major IVF clinics have changed how they advertise success rates after an investigation by the Australian Competition and Consumer Commission found a number had made misleading claims which could confuse consumers.
“We had concerns with a significant proportion of the clinics,” Ms Court said.
The concerns fell into two general areas: the use of medical terms in advertising which could confuse the lay person, and selective reporting of success rates.
For example, some clinics advertised a “clinical pregnancy rate” which an average person might understand to mean a live birth of a baby, but actually included ectopic pregnancies or pregnancies where no heartbeat was ever detected.
Selective reporting of success rates included only reporting the number of cycles at the clinic in question, not failed cycles at other clinics.
“For example, a clinic reporting, say, an 85 per cent success rate within two cycles might have not included five previous failed cycles for that woman at another clinic,” Ms Court said.
Both types of claims could mislead consumers, she said.
Full Content: ABC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
CVS Health Explores Potential Breakup Amid Investor Pressure: Report
Oct 3, 2024 by
CPI
DirecTV Acquires Dish TV, Creating 20 Million-Subscriber Powerhouse
Oct 3, 2024 by
CPI
South Korea Fines Kakao Mobility $54.8 Million for Anti-Competitive Practices
Oct 3, 2024 by
CPI
Google Offers Settlement in India’s Antitrust Case Regarding Smart TVs
Oct 3, 2024 by
CPI
Attorney Challenges NCAA’s $2.78 Billion Settlement in Landmark Antitrust Cases
Oct 3, 2024 by
nhoch@pymnts.com
Antitrust Mix by CPI
Antitrust Chronicle® – Refusal to Deal
Sep 27, 2024 by
CPI
Antitrust’s Refusal-to-Deal Doctrine: The Emperor Has No Clothes
Sep 27, 2024 by
Erik Hovenkamp
Why All Antitrust Claims are Refusal to Deal Claims and What that Means for Policy
Sep 27, 2024 by
Ramsi Woodcock
The Aspen Misadventure
Sep 27, 2024 by
Roger Blair & Holly P. Stidham
Refusal to Deal in Antitrust Law: Evolving Jurisprudence and Business Justifications in the Align Technology Case
Sep 27, 2024 by
Timothy Hsieh